NCT00280527 Protocol for the Assessment of Variability in Histology and Gene Expression in Bariatric Surgery Patients. Status COMPLETED Phase N/A
NCT00278655 Hematopoietic Stem Cell Therapy for Patients With Multiple Sclerosis Status TERMINATED Phase PHASE1/PHASE2
NCT00278629 Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy Status COMPLETED Phase PHASE2
NCT00278590 Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus Status WITHDRAWN Phase PHASE1
NCT00278564 Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases Status TERMINATED Phase PHASE1
NCT00278538 Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE2
NCT00278525 Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma Status COMPLETED Phase PHASE2
NCT00278369 Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer Status COMPLETED Phase EARLY_PHASE1
NCT00276835 Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer Status COMPLETED Phase EARLY_PHASE1
NCT00276783 Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases Status UNKNOWN Phase PHASE2
NCT00275067 Arsenic Trioxide, Temozolomide, and Radiation Therapy in Treating Patients With Malignant Glioma That Has Been Removed By Surgery Status UNKNOWN Phase PHASE1/PHASE2
NCT00273364 Stem Cell Therapy for Patients With Multiple Sclerosis Failing Alternate Approved Therapy- A Randomized Study Status COMPLETED Phase PHASE2
NCT00271934 Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study Status COMPLETED Phase PHASE2
NCT00267670 Pentoxifylline/Nonalcoholic Steatohepatitis (NASH) Study: The Effect of Pentoxifylline on NASH Status COMPLETED Phase PHASE2/PHASE3